Because the CONCERTA tablet is nondeformable and does not appreciably transform in form inside the GI tract, CONCERTA should not ordinarily be administered to patients with preexisting intense gastrointestinal narrowing (pathologic or iatrogenic, as an example: esophageal motility disorders, modest bowel inflammatory illness, "small intestine" synd